Burden of stroke in Singapore

International Journal of Stroke

Volumn 3, Issue 1, 2008, Pages 51-54

  Venketasubramanian, N ^a   Chen, C L H ^b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Asian; Cerebrovascular disease; Epidemiology

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; DISEASE CLASSIFICATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; MORTALITY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REHABILITATION CARE; RISK FACTOR; RISK REDUCTION; SINGAPORE;

AGE FACTORS; CAUSE OF DEATH; COST OF ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PREVALENCE; SINGAPORE; STROKE;

EID: 38949209517     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2008.00181.x     Document Type: Article

References (21)

1. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-42.
2. Burke TA, Venketasubramanian N: The epidemiology of stroke in the East Asian region: A literature-based review. Int J Stroke 2006; 1:208-15.
3. Ministry of Health, Singapore http://www.moh.gov.sg/mohcorp/default.aspx
4. Venketasubramanian N: Stroke in Singapore - an overview. Singapore Med J 1999; 40:48-52.
5. Venketasubramanian N: Trends in cerebrovascular disease mortality in Singapore: 1970-1994. Int J Epidemiol 1998; 27:15-9.
6. Venketasubramanian N: Interethnic differences in cerebrovascular disease mortality in Singapore. Cerebrovasc Dis 1996; 6(Suppl. 2): 61.
7. Venketasubramanian N, Tan LC, Sahadevan S et al. Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: A community-based tri-racial cross-sectional survey. Stroke 2005; 36:551-6.
8. Heng DM, Lee J, Chew SK, Tan BY, Hughes K, Chia KS: Incidence of ischaemic heart disease and stroke in Chinese, Malays and Indians in Singapore: Singapore Cardiovascular Cohort Study. Ann Acad Med Singapore 2000; 29:231-6.
9. Venketasubramanian N, Yin A: Hospital costs for stroke care in Singapore. Cerebrvasc Dis 2000; 10:320-6.
10. Venketasubramanian N, Tan AKY, Sadasivan B: Stroke patterns in a hospital-based stroke data bank. Cerebrovasc Dis 1994; 4:250.
11. De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC: South Asian patients with ischemic stroke: Intracranial large arteries are the predominant site of disease. Stroke 2007; 38:2592-4.
12. De Silva DA, Woon FP, Lee MP et al. Ischemic cerebrovascular disease: differences between ethnic South Asian and ethnic Chinese patients. Cerebrovasc Dis 2005; 20:407-9.
13. Ministry of Health, Singapore. Singapore National Health Survey 2004.
14. Yap KB, Ng TP, Ong HY: Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: A population-based study. J Electrocardiol 2007 May 23; doi: [Epub ahead of print].
15. Singapore Medical Council. Singapore: http://www.smc.gov.sg/PRSCPDS/ scripts/profSearch/profframe.jsp?param=&board=SMC
16. Singapore National Stroke Association: http://www.snsa.org.sg/
17. International Stroke Trial Collaboration Group. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-81.
18. Muir KW, Lees KR, Ford I, Davis S: Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomised controlled trial. Lancet 2004; 363:439-45.
19. The ESPRIT Study Group Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomized controlled trial. Lancet 2006; 367:1665-73.
20. Wong KS, Chen C, Ng PW et al. A randomized study comparing low-molecular weight-heparin with aspirin for the treatment of ischemic stroke patients with large artery disease in Asians. Lancet Neurol 2007; 6:407-13.
21. Tan CC: National disease management plans for key chronic non-communicable diseases in Singapore. Ann Acad Med Singapore 2002; 31:415-8.